Baicalin is a biologically active flavonoid compound that benefits the organism in various
pathological conditions. Rodent studies have shown that this compound effectively …

Background: Biosynthetic human insulins and analogs have replaced animal insulins and
permitted structural modifications to alter the rate of absorption, duration of action, improve …

Mesenchymal stem cells (MSCs) hold great potential in treating patients with diabetes, but
the therapeutic effects are not always achieved. Particularly, the clinical factors regulating …

Type 2 diabetes mellitus is a progressive disease, which requires insulin treatment when
other management is no longer effective. Although, insulin plays a vital role in the treatment …

Aim To report the effectiveness and safety of insulin glargine 300 U/mL (Gla‐300) versus
standard‐of‐care basal insulin analogues (SOC‐BI) at 12 months in the ACHIEVE Control …

Aims To better understand outcomes in people with type 2 diabetes at high risk of
hypoglycemia, we conducted post hoc analyses in subgroups of participants from the real …

Aims: To investigate how switching from insulin glargine U-100 (Gla-100) to insulin glargine
U-300 (Gla-300) affects glycemic control and treatment satisfaction in Japanese people with …

In a healthy individual, rapid insulin releases from pancreatic β-cells of Langerhans is
observed after ingestion of meal. Post a mixed meal, endogenous insulin level is observed …

Many people with type 2 diabetes are treated with insulin with the goal of achieving a
specific A1C target. The most prominent risk for people on insulin therapy is hypoglycemia …

Pagina 4 – Il Diabete Online All Journals Il Diabete Online Organo ufficiale della Società
Italiana di Diabetologia Home Ultimo numero Abstract Volumi pubblicati “il diabete” SID …